Combined heart-liver transplantation: a single-center experience

Transpl Int. 2015 Jul;28(7):828-34. doi: 10.1111/tri.12549. Epub 2015 Mar 9.

Abstract

Combined orthotopic heart and liver transplantation (CHLT) is a lifesaving procedure for patients with end-stage heart-liver disease. We reviewed the long-term outcome of patients who have undergone CHLT at the University of Bologna, Italy. Fifteen patients with heart and liver failure were placed on the transplant list between November 1999 and March 2012. The pretransplant cardiac diagnoses were familial amyloidosis in 14 patients and chronic heart failure due to chemotherapy with liver failure due to chronic hepatitis in one patient. CHLT was performed as a single combined procedure in 14 hemodynamically stable patients; there was no peri-operative mortality. The survival rates for the CHLT recipients were 93%, 93%, and 82% at 1 month and 1 and 5 years, respectively. Freedom from graft rejection was 100%, 90%, and 36% at 1, 5, and 10 years, respectively, for the heart graft and 100%, 91%, and 86% for the liver graft. The livers of eight recipients were transplanted as a "domino" with mean overall 1-year survival of 93%. Simultaneous heart and liver transplantation is feasible and was achieved in this extremely sick cohort of patients. By adopting the domino technique, we were able to enlarge the donor cohort and include high-risk patients.

Keywords: combined heart-liver transplant; domino transplant; multi-organ transplant.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • End Stage Liver Disease / complications
  • End Stage Liver Disease / mortality
  • End Stage Liver Disease / surgery*
  • Female
  • Graft Survival
  • Heart Failure / complications
  • Heart Failure / mortality
  • Heart Failure / surgery*
  • Heart Transplantation / methods*
  • Heart Transplantation / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Liver Transplantation / methods*
  • Liver Transplantation / mortality
  • Male
  • Middle Aged
  • Survival Rate
  • Treatment Outcome